A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervix
- 1 March 2005
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (4), 523-530
- https://doi.org/10.1016/j.ejca.2004.12.013
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The Risk of Cancer in Users of StatinsJournal of Clinical Oncology, 2004
- Erlotinib: a new therapeutic approach for non-small cell lung cancerExpert Opinion on Investigational Drugs, 2003
- HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosisLeukemia, 2002
- Lovastatin Induces a Pronounced Differentiation Response in Acute Myeloid LeukemiasLeukemia & Lymphoma, 2000
- The HypobetalipoproteinemiasAnnual Review of Nutrition, 1995
- Pharmacology of competitive inhibitors of HMg-CoA reductasePharmacological Research, 1995
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)The Lancet, 1994
- Cancer statistics, 1994CA: A Cancer Journal for Clinicians, 1994
- HMG CoA reductase inhibitorsCurrent Opinion in Lipidology, 1992
- Regulation of the mevalonate pathwayNature, 1990